AI-generated summary
The authors retrospectively reviewed medical files of 61 patients with dry eye disease caused by demodex blepharitis who received intense pulsed light plus topical ivermectin 1%. They report significant improvement in meibomian gland secretion grading and blepharitis elimination in 77.0% of patients, with no significant side effects observed. The study had no control group, and the authors state that randomized controlled double-blinded studies are needed.
- Participants
- 61
- Who or what was studied
- Patients aged 18 years or older with dry eye disease secondary to demodex blepharitis treated at a private clinic specializing in dry eye disease
- Limits stated in the abstract
- The study was a retrospective review without a control group, and the authors state that randomized controlled double-blinded studies are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.